Share Name Share Symbol Market Type Share ISIN Share Description
Verona Pharma LSE:VRP London Ordinary Share GB00BYW2KH80 ORD 5P
  Price Change % Change Share Price Shares Traded Last Trade
  +2.50p +2.02% 126.00p 35,588 13:39:00
Bid Price Offer Price High Price Low Price Open Price
122.00p 130.00p 130.00p 123.50p 123.50p
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology -25.20 -23.40 64.7

Verona Pharma (VRP) Latest News

More Verona Pharma News
Verona Pharma Takeover Rumours

Verona Pharma (VRP) Share Charts

1 Year Verona Pharma Chart

1 Year Verona Pharma Chart

1 Month Verona Pharma Chart

1 Month Verona Pharma Chart

Intraday Verona Pharma Chart

Intraday Verona Pharma Chart

Verona Pharma (VRP) Discussions and Chat

Verona Pharma Forums and Chat

Date Time Title Posts
11/7/201800:19Verona Pharma: Developing first in class drugs for respiratory diseases989
16/2/201517:30Verona Pharma with Charts & News11,549
24/11/201112:54verona pharma173
19/9/201114:14verona pharma8
15/9/200908:29verona pharma30

Add a New Thread

Verona Pharma (VRP) Most Recent Trades

No Trades
Trade Time Trade Price Trade Size Trade Value Trade Type
View all Verona Pharma trades in real-time

Verona Pharma (VRP) Top Chat Posts

Verona Pharma Daily Update: Verona Pharma is listed in the Pharmaceuticals & Biotechnology sector of the London Stock Exchange with ticker VRP. The last closing price for Verona Pharma was 123.50p.
Verona Pharma has a 4 week average price of 115p and a 12 week average price of 115p.
The 1 year high share price is 197.50p while the 1 year low share price is currently 100.50p.
There are currently 51,361,064 shares in issue and the average daily traded volume is 11,406 shares. The market capitalisation of Verona Pharma is £64,714,940.64.
combo83: The risk/reward here currently looks very favourable. Well funded, important newsflow within 1-2 months, consistent director buying, and different brokers with price targets at multiples of the current share price. GLA, could be a very interesting year. PS - timboo, perhaps time for an update of the header? :)
haff1: Its a shame the share price doesnt reflect this..
kwizza: Is this a new low for the share price
shakin not stirred: I am waiting to see if Nasdaq listing makes a difference but need to get to £2 new money to break even. Will bale out when that is reached. Unless anything materially changes as to indicating a good news flow. At the moment it is a Jam tomorrow as have been the last few years for me and longer for others. None of us have invested in companys for F.A. but that is the current return at this moment in time. That is the current reality of the share price.
vasilis: Phase 2a COPD trial official start as first patient dosed with expected top-line results in Q4 -
timbo003: The recent share price movement is a bit disappointing, but similar to that of Motif Bio immediately before it had its Nasdaq listing. With US listings for UK listed AIM companies, be careful of what you wish for!
meijiman: The share price has not been too clever of late.......
shakin not stirred: The belief is that the minimum share price on the nasdaq is $2 so that will happen and in my mind we will be fully subscribed and job don e with enough money to take it to commercialisation and GSK or alternatively large paharma like Bayer to buy a huge lump of shares, followed by a partnership deal. 9p equivalent old money this year and 20p eventual. All very good news.
timbo003: I hope the US listing goes somewhat better than it did for Motif Bio (MTFB), which was a disaster as far as the share price was concerned
weeklynews: RightBus? The way the VRP share price is flying, I been soon catching taxis to work. RegardsWeeklynews
Verona Pharma share price data is direct from the London Stock Exchange
add chat code
Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:43 V: D:20180721 17:29:59